Tokyo, Japan

Shinichi Oikawa

USPTO Granted Patents = 3 



Average Co-Inventor Count = 11.2

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovator Shinichi Oikawa: Pioneering Medical Solutions

Introduction: Shinichi Oikawa is a notable inventor based in Tokyo, Japan. With a focus on medical innovations, he has secured a total of three patents that contribute significantly to the fields of diabetes and cardiovascular health.

Latest Patents: Among his latest inventions, Oikawa has developed a composition aimed at reducing new-onset diabetes. This medical composition targets the adverse effects associated with statin administration, offering a potential solution for managing blood glucose levels. The composition includes at least one ingredient selected from icosapentaenoic acid and its pharmaceutically acceptable salts or esters. Another noteworthy patent pertains to a composition and/or method designed for preventing the onset and recurrence of cardiovascular events. This innovation is particularly beneficial for patients who have successfully overcome the unstable period following cardiovascular angioplasty or for those suffering from hyperlipidemia and treated with HMG-CoA reductase inhibitors.

Career Highlights: Shinichi Oikawa is employed by Mochida Pharmaceutical Co., Ltd., where he works extensively on improving medical treatments through his inventions. His contributions have been instrumental in advancing pharmaceutical science in Japan.

Collaborations: Throughout his career, Oikawa has collaborated with esteemed colleagues, including Mitsuhiro Yokoyama and Hideki Origasa. These partnerships underscore the value of teamwork in fostering innovation in research and development within the pharmaceutical industry.

Conclusion: Shinichi Oikawa stands out as a dedicated inventor whose work continues to shape the future of medical solutions. His innovative compositions not only aim to address complex health issues but also contribute to the broader field of medical research and development. With his relentless pursuit of advancements, Oikawa exemplifies the spirit of innovation essential to improving patient outcomes globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…